Clinical and biological significance of HSP89 alpha in human breast cancer
about
Expressional patterns of chaperones in ten human tumor cell lines.Heat shock proteins at the crossroads between cancer and Alzheimer's diseaseFunctions of the Hsp90 chaperone system: lifting client proteins to new heightsRegulation and function of the human HSP90AA1 geneHeat shock protein 90 inhibition: rationale and clinical potential.Heat shock protein expression in canine malignant mammary tumours.To fold or not to fold: modulation and consequences of Hsp90 inhibition.Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implicationsHSP90 as a new therapeutic target for cancer therapy: the story unfolds.The cochaperone p23 differentially regulates estrogen receptor target genes and promotes tumor cell adhesion and invasionMALDI-MSI and label-free LC-ESI-MS/MS shotgun proteomics to investigate protein induction in a murine fibrosarcoma model following treatment with a vascular disrupting agent.Proteomics: a strategy to understand the novel targets in protein misfolding and cancer therapy.A dynamic view of ATP-coupled functioning cycle of Hsp90 N-terminal domain.Secreted heat shock protein-90 (Hsp90) in wound healing and cancer.Do heat shock proteins have a role in breast cancer?Antibodies to heat-shock protein 27 are associated with improved survival in patients with breast cancer.Down-regulation of Hsp90 could change cell cycle distribution and increase drug sensitivity of tumor cells.Heat shock proteins in animal neoplasms and human tumours--a comparisonInhibition of heat shock protein 90 (HSP90) as a therapeutic strategy for the treatment of myeloma and other cancers.Heat shock protein as molecular targets for breast cancer therapeutics.Cellular and molecular mechanisms in cancer immune escape: a comprehensive review.The stress response paradox: fighting degeneration at the cost of cancer.AUY922 effectively targets against activated B cell subtype of diffuse large B-cell lymphoma and low-grade lymphoma cells harboring genetic alteration-associated nuclear factor-κB activation.Monitoring the induction of heat shock factor 1/heat shock protein 70 expression following 17-allylamino-demethoxygeldanamycin treatment by positron emission tomography and optical reporter gene imaging.BCR-ABL1-induced expression of HSPA8 promotes cell survival in chronic myeloid leukaemia.Spheroid growth in ovarian cancer alters transcriptome responses for stress pathways and epigenetic responses.Interleukin-10 activates heat-shock protein 90beta gene expression.Heat shock factor 2 is associated with the occurrence of lung cancer by enhancing the expression of heat shock proteins.Structural determination of three different series of compounds as Hsp90 inhibitors using 3D-QSAR modeling, molecular docking and molecular dynamics methods.Significance of expression of heat shock protein90alpha in human gastric cancer.A systematic atlas of chaperome deregulation topologies across the human cancer landscape.Heat shock protein 72 modulates pathways of stress-induced apoptosis.Prognostic significance of heat shock proteins HSP70 and HSP90 in endometrial carcinomas.Expression of heat shock proteins HSP70 and HSP90 in endometrial carcinomas. Correlation with clinicopathology, sex steroid receptor status, and p53 protein expression.Expression and roles of heat shock proteins in human breast cancer.Down-regulated expression of HSP70 in correlation with clinicopathology of cholangiocarcinoma.[The correlation between the up-regulation of Hsp90 and drug resistance to cisplatin in lung cancer cell line].
P2860
Q24798540-209FE892-7448-4AFE-92A7-1B3EB409C50BQ26864311-1B1D6672-6031-4396-8551-17FC424AB1A8Q27024085-927BA0A6-4836-4A06-9EFC-BC44C98BF72CQ28646043-16563105-38B6-4AA0-A7AE-58A606F679D5Q30418761-E6DDE04F-3D3F-4A86-AAA6-0F43DD82F493Q33248080-A29BAED8-7340-4E3F-A1E3-0CE00F014BEAQ33531705-A585FA4D-FAE9-4905-804F-BCFFECE8C56BQ33899708-AC0E14C1-237B-4992-A61D-1A782E0AD01AQ34482045-DC0505D2-F477-4ABC-98BA-AD91AA9F45B5Q35070908-37CB7AFB-F7AF-4EEC-BD68-5B082723477BQ35092529-EF89C475-64D2-420C-BC01-7970B3D5F1C8Q35116243-CF6DD7BC-FA1E-48F4-A531-AFC21BD3DDAAQ35384807-2D762B55-6BCA-4A59-96D2-9C051C0166EFQ35696767-ED38C092-B61A-4C10-B984-32598557A97EQ36136058-BDC4BA65-3534-4F8D-9ADE-1E1BF57440D8Q36292805-F3FE63D4-BD34-4C44-979C-6BA29D6BE6C7Q36396741-6C25AA9F-1DFA-4E95-ACB6-9E7FD2375244Q37107963-1A4E8525-E6DC-436B-949C-FE1252095583Q37827173-6C696E0A-CCE5-4BC7-BE34-1BE49239236CQ37949966-A6618405-AFF1-4809-814A-E330AAE02CD0Q38170150-8464EACE-FE14-4CAB-BFAE-B038D3B94410Q38844265-42FEEB25-58E0-43A0-9E75-03233C1EA87FQ38925954-8FD27370-3955-4017-B3AF-5E79DBB58089Q39379718-145BEEC0-6DB6-4B5D-BBF4-1E0E761FA5B5Q39974408-33014DBB-850D-4925-93FD-7A88DBA349BAQ40089027-30F136AC-569B-4503-8620-F1E84F57D7D1Q40935346-8E9353E1-080F-4159-9F62-9BDD5863A2CAQ41379308-805C415A-C065-46C5-9787-51CA9671C66FQ41887179-C3028227-D303-464E-8A35-21962468BC19Q43159642-9C312902-8968-4AA3-96FF-6256F8B1E188Q47205509-1818B197-8ADB-4A2A-AF2F-F5BF8B87CF21Q47921342-D05D3599-E200-4604-B18F-0B048F36A1F8Q50856443-C9093BCD-04CA-4EB0-81EF-3A96F5311347Q51033804-5022C112-3C8E-4E28-B24B-ECC9EC7C915BQ53451551-732075C2-C5F8-4748-B4E2-A5B97797C335Q54359831-6504DCD8-7941-49A8-BB56-400A18C9B10AQ55445773-7BB90AAF-3DD6-4453-AE5F-C95401A438B9
P2860
Clinical and biological significance of HSP89 alpha in human breast cancer
description
1992 nî lūn-bûn
@nan
1992 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Clinical and biological significance of HSP89 alpha in human breast cancer
@ast
Clinical and biological significance of HSP89 alpha in human breast cancer
@en
Clinical and biological significance of HSP89 alpha in human breast cancer
@nl
type
label
Clinical and biological significance of HSP89 alpha in human breast cancer
@ast
Clinical and biological significance of HSP89 alpha in human breast cancer
@en
Clinical and biological significance of HSP89 alpha in human breast cancer
@nl
prefLabel
Clinical and biological significance of HSP89 alpha in human breast cancer
@ast
Clinical and biological significance of HSP89 alpha in human breast cancer
@en
Clinical and biological significance of HSP89 alpha in human breast cancer
@nl
P2093
P2860
P356
P1476
Clinical and biological significance of HSP89 alpha in human breast cancer
@en
P2093
R A Skilton
R C Coombes
S K Chander
T A Campbell
Y A Luqmani
P2860
P304
P356
10.1002/IJC.2910500315
P407
P577
1992-02-01T00:00:00Z